Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Everest Medicines

Biotech & Life Sciences · New York City, United States · Founded 2017 · IPO 2020 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$1.25B
Market cap · Apr/2026
Revenue
$235M
Latest reported FY

Investors

6 investors on Everest Medicines's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 3 investors entered at this stage
Cormorant Asset Management
HBM Healthcare Investments
CBC Group
Series B+ 3 investors entered at this stage
Hillhouse Capital
Janchor Partners
RA Capital Management

Global footprint

Where Everest Medicines has talent and traffic

Web traffic by country
56K monthly visits
across markets
🇨🇳 China94.1%
🇺🇸 United States3.4%
🇮🇳 India1.1%
🇭🇰 Hong Kong0.9%
Top 4 markets shown

See Everest Medicines on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo